Lv1
20 积分 2025-04-27 加入
Is there Evidence for a Continued Benefit for Long-Term Lecanemab Treatment? A Benefit/Risk Update from Long-Term Efficacy, Safety and Biomarker Data
3天前
已完结
ARIA by clinical diagnosis and baseline amyloid PET levels: a subgroup analysis of clarity AD
4天前
待确认
Structural dynamics of amyloid‑β protofibrils and actions of anti‑amyloid‑β antibodies as observed by high‑speed atomic force microscopy
4天前
已完结
皖公网安备34019202002308
